Terns Pharmaceuticals
TERN
TERN
103 hedge funds and large institutions have $505M invested in Terns Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
20% less capital invested
Capital invested by funds: $630M → $505M (-$125M)
69% less call options, than puts
Call options by funds: $3.35M | Put options by funds: $10.7M
Holders
103
Holding in Top 10
6
Calls
$3.35M
Puts
$10.7M
Top Buyers
| 1 | +$21.3M | |
| 2 | +$18.5M | |
| 3 | +$10.5M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$9.62M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.17M |
Top Sellers
| 1 | -$16M | |
| 2 | -$7.45M | |
| 3 | -$7.42M | |
| 4 |
VA
VR Adviser
New York
|
-$5.66M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.18M |